AngioDynamics, Inc. (ANGO) Operating Margin
- Operating margin · 12 months: Value -12.47%; Formula and calculation Operating income / revenue. Period ending 2026-05-31..
Operating margin
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -12.47% | Operating income / revenue. Period ending 2026-05-31. $-39.93M ÷ $320.17M × 100 ≈ -12.47% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -39.93M USD | Operating Income (Loss) |
| Revenue | 320.17M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 145.28M USD | Cost of Goods and Services Sold |
| Research and development | 29.45M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-05-31 | $-39.93M | $320.17M | $145.28M | $29.45M | (m) | -12.47% |
| 2026-02-28 | $-35.52M | $313.73M | $143.39M | $27.86M | (m) | -11.32% |
| 2025-11-30 | $-32.54M | $307.31M | $139.59M | $27.69M | (m) | -10.59% |
| 2025-08-31 | $-37.51M | $300.72M | $137.88M | $26.35M | (m) | -12.47% |
| 2025-05-31 | $-39.95M | $292.50M | $134.79M | $26.22M | (m) | -13.66% |
| 2025-02-28 | $-48.62M | $283.32M | $129.32M | $26.36M | (m) | -17.16% |
| 2024-11-30 | $-238.54M | $286.50M | $135.49M | $27.63M | (m) | -83.26% |
| 2024-08-31 | $-240.56M | $292.73M | $141.36M | $29.86M | (m) | -82.18% |
| 2024-05-31 | $-192.44M | $303.91M | $149.22M | $31.51M | (m) | -63.32% |
| 2024-02-29 | $-198.82M | $324.01M | $161.47M | $32.65M | (m) | -61.36% |
| 2023-11-30 | $-7.86M | $329.54M | $162.35M | $31.31M | (m) | -2.38% |
| 2023-08-31 | $-2.85M | $335.89M | $163.89M | $29.49M | (m) | -0.85% |
| 2023-05-31 | $-51.18M | $338.75M | $164.51M | $29.88M | (m) | -15.11% |
| 2023-02-28 | $-36.74M | $334.68M | $160.33M | $29.89M | (m) | -10.98% |
| 2022-11-30 | $-33.11M | $327.93M | $155.51M | $30.32M | (m) | -10.10% |
| 2022-08-31 | $-33.67M | $320.79M | $152.89M | $31.68M | (m) | -10.50% |
| 2022-05-31 | $-28.47M | $316.22M | $150.49M | $30.74M | (m) | -9.00% |
| 2022-02-28 | $-43.66M | $306.06M | $144.47M | $31.98M | (m) | -14.27% |
| 2021-11-30 | $-42.10M | $303.27M | $141.73M | $33.26M | (m) | -13.88% |
| 2021-08-31 | $-38.26M | $297.76M | $136.60M | $34.77M | (m) | -12.85% |
| 2021-05-31 | $-35.28M | $291.01M | $134.22M | $36.39M | (m) | -12.12% |
| 2021-02-28 | $-170.31M | $272.50M | $127.82M | $34.52M | (m) | -62.50% |
| 2020-11-30 | $-172.81M | $271.10M | $124.65M | $34.35M | (m) | -63.74% |
| 2020-08-31 | $-171.39M | $268.33M | $120.51M | $32.40M | (m) | -63.87% |
| 2020-05-31 | $-167.10M | $264.16M | $113.89M | $29.68M | (m) | -63.26% |
| 2020-02-29 | $-7.55M | $277.01M | $115.62M | $29.34M | (m) | -2.73% |
| 2019-11-30 | $-4.99M | $272.75M | $113.50M | $27.86M | (m) | -1.83% |
| 2019-08-31 | $-4.09M | $272.73M | $114.47M | $27.18M | (m) | -1.50% |
| 2019-05-31 | $-9.40M | $270.63M | $114.63M | $28.26M | (m) | -3.47% |
| 2019-02-28 | $11.53M | $351.50M | $163.77M | $28.69M | (m) | 3.28% |
| 2018-11-30 | $13.60M | $349.01M | $162.52M | $27.94M | (m) | 3.90% |
| 2018-08-31 | $10.74M | $344.21M | $164.10M | $26.68M | (m) | 3.12% |
| 2018-05-31 | $10.56M | $344.29M | $167.41M | $25.46M | (m) | 3.07% |
| 2018-02-28 | $-5.21M | $342.88M | (m) | $25.70M | (m) | -1.52% |
| 2017-11-30 | $-4.93M | $344.63M | (m) | $25.20M | (m) | -1.43% |
| 2017-08-31 | $9.54M | $346.96M | (m) | $25.00M | (m) | 2.75% |
| 2017-05-31 | $12.97M | $349.64M | (m) | $25.27M | (m) | 3.71% |
| 2017-02-28 | $22.58M | $356.15M | (m) | $25.51M | (m) | 6.34% |
| 2016-11-30 | $19.40M | $357.98M | (m) | $25.37M | (m) | 5.42% |
| 2016-08-31 | $4.38M | $358.24M | (m) | $25.63M | (m) | 1.22% |
| 2016-05-31 | $1.02M | $353.89M | (m) | $25.05M | (m) | 0.29% |
| 2016-02-29 | $6.41M | $351.22M | (m) | $25.48M | (m) | 1.83% |
| 2015-11-30 | $-6.42M | $350.43M | (m) | $26.52M | (m) | -1.83% |
| 2015-08-31 | $-3.17M | $353.35M | (m) | $26.41M | (m) | -0.90% |
| 2015-05-31 | $-994.00K | $356.97M | (m) | $26.93M | (m) | -0.28% |
| 2015-02-28 | $1.25M | $360.14M | (m) | $26.37M | (m) | 0.35% |
| 2014-11-30 | $17.91M | $361.69M | (m) | $26.56M | (m) | 4.95% |
| 2014-08-31 | $14.78M | $358.11M | (m) | $27.52M | (m) | 4.13% |
| 2014-05-31 | $13.45M | $354.45M | (m) | $27.51M | (m) | 3.79% |
| 2014-02-28 | $11.66M | $350.42M | (m) | $27.20M | (m) | 3.33% |
| 2013-11-30 | $4.15M | $343.80M | (m) | $25.94M | (m) | 1.21% |
| 2013-08-31 | $7.70M | $342.20M | (m) | $25.95M | (m) | 2.25% |
| 2013-05-31 | $7.09M | $342.03M | (m) | $26.32M | (m) | 2.07% |
| 2013-02-28 | $-984.00K | $309.68M | (m) | $25.10M | (m) | -0.32% |
| 2012-11-30 | $-3.80M | $279.68M | (m) | $23.88M | (m) | -1.36% |
| 2012-08-31 | $-5.00M | $250.76M | (m) | $21.99M | (m) | -1.99% |
| 2012-05-31 | $-2.96M | $221.79M | (m) | $20.51M | (m) | -1.34% |
| 2012-02-29 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-11-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-08-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-08-30 | (m) | $218.67M | (m) | (m) | (m) | (m) |
| 2011-05-31 | $11.96M | $215.75M | (m) | $21.37M | (m) | 5.54% |
| 2011-02-28 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-11-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-08-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-05-31 | $20.87M | $216.03M | (m) | $19.27M | (m) | 9.66% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |